Profiel
Marc J.
Lajoie is the founder of GRO Biosciences, Inc. (founded in 2016) and holds the title of Advisor.
Dr. Lajoie is also the founder of Outpace Bio, Inc...
Actieve functies van Marc J. Lajoie
| Bedrijven | Functie | Begin |
|---|---|---|
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Oprichter | 01-01-2016 |
Outpace Bio, Inc.
 Outpace Bio, Inc. BiotechnologyHealth Technology Outpace Bio, Inc. is a company that creates smart cell therapies using protein design and synthetic biology to reprogram how cells function and make decisions. The company is based in Seattle, WA. The company collaborates with industry leaders to improve the safety and efficacy of cell and gene therapies. Outpace's platform combines the design of improved biological functions with powerful cellular control modalities to tackle incurable diseases. Outpace Bio was founded by Marc J. Lajoie and Scott Boyken, and Marc J. Lajoie has been the CEO since incorporation. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Outpace Bio, Inc.
Outpace Bio, Inc. BiotechnologyHealth Technology Outpace Bio, Inc. is a company that creates smart cell therapies using protein design and synthetic biology to reprogram how cells function and make decisions. The company is based in Seattle, WA. The company collaborates with industry leaders to improve the safety and efficacy of cell and gene therapies. Outpace's platform combines the design of improved biological functions with powerful cellular control modalities to tackle incurable diseases. Outpace Bio was founded by Marc J. Lajoie and Scott Boyken, and Marc J. Lajoie has been the CEO since incorporation. | Health Technology |
